The Indian Competition Authority approves a merger of two global pharmaceutical companies because they operate in separate markets in the country (Pfizer / Hospira / Perkins)

Sharma, Man Mohan

Previous article The EU Commission clears a merger subject to remedies in the pharmaceutical sector (Merck / Sigma-Aldrich) Next article The US FTC challenges a merger in regional markets for sterilization of products using radiation based on future competition concerns (Steris / Synergy Health)

11 Jun 2015

The Indian Competition Authority approves a merger of two global pharmaceutical companies because they operate in separate markets in the country (Pfizer / Hospira / Perkins)

KEYWORDS

Reference

Competition Commission of India, Combination Registration No. C-2015/03/255, Pfizer / Hospira / Perkins, 11 June 2015

CCI approves merger of Pfizer, Hospira, Inc. and Perkins Holding Company* CCI by its order dated June 11, 2015 approved the execution of an Agreement and Plan of Merger between Pfizer, Hospira, Inc. (Hospira) and Perkins Holding Company (Perkins), a

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Man Mohan Sharma
Vaish Associates Advocates (New Delhi)

India 263 contributions 41154 visits

Quotation

Man Mohan Sharma, The Indian Competition Authority approves a merger of two global pharmaceutical companies because they operate in separate markets in the country (Pfizer / Hospira / Perkins), 11 June 2015, e-Competitions Pharma & Mergers, Art. N° 87357

Visites 117